ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Ruthenium-dihydroartemisinin complex: a promising new compound for colon cancer prevention via G1 cell cycle arrest, apoptotic induction, and adaptive immune regulation

Wang, Chong-Zhi*; Wan, Chunping; Li, Cang-Hai; Liang, Guo-Gang; Luo, Yun; Zhang, Chun-Feng; Zhang, Qi-Hui; Ma, Qinge; Wang, Angela H.; Lager, Mallory; Jiang, Ting-Liang; Hou, Lifei; Yuan, Chun-Su重庆大学; 1
Cancer Chemotherapy and Pharmacology2024-1-9DOI: 10.1007/s00280-023-04623-7
7阅读
引用收藏
分享

摘要

BackgroundArtemisinin (ART) and its derivatives are important antimalaria agents and have received increased attention due to their broad biomedical effects, such as anticancer and anti-inflammation activities. Recently, ruthenium-derived complexes have attracted considerable attention as their anticancer potentials were observed in preclinical and clinical studies.MethodsTo explore an innovative approach in colorectal cancer (CRC) management, we synthesized ruthenium-dihydroartemisinin complex (D-Ru), a novel metal-based artemisinin derivative molecule, and investigated its anticancer, anti-inflammation, and adaptive immune regulatory properties.ResultsCompared with its parent compound, ART, D-Ru showed stronger antiproliferative effects on the human CRC cell lines HCT-116 and HT-29. The cancer cell inhibition of D-Ru comprised G1 cell cycle arrest via the downregulation of cyclin A and the induction of apoptosis. ART and D-Ru downregulated the expressions of pro-inflammatory cytokines IL-1 beta, IL-6, and IL-8. Although ART and D-Ru did not suppress Treg cell differentiation, they significantly inhibited Th1 and Th17 cell differentiation.ConclusionsOur results demonstrated that D-Ru, a novel ruthenium complexation of ART, remarkably enhanced its parent compound's anticancer action, while the anti-inflammatory potential was not compromised. The molecular mechanisms of action of D-Ru include inhibition of cancer cell growth via cell cycle arrest, induction of apoptosis, and anti-inflammation via regulation of adaptive immunity.

学科与关键词

关键词
ArtemisininRuthenium-dihydroartemisinin complexCell cycle and apoptosisInflammationAdaptive immunityColorectal cancer
相关
加载中…
  • Effects of dihydroartemisinin, a metabolite of artemisinin, on colon cancer chemoprevention and adaptive immune regulation
    Wang, Chong-Zhi*; Wan, Chunping; Luo, Yun; Zhang, Chun-Feng; Zhang, Qi-Hui; Chen, Lina; Liu, Zhi; Wang, Daniel H.; Lager, Mallory; Li, Cang-Hai; Jiang, Ting-Liang; Hou, Lifei; Yuan, Chun-SuMolecular Biology Reports, 2022, 49(4): 2695-2709.被引 6
  • Discovery of PlatinumIV-Artesunate Multiaction Prodrugs as Potent Antitumor and Antimalarial Agents
    Liu, Wei; Yu, Chuyi; Wang, Miaomiao; He, Youyou; Guo, Zhongjie; He, Jin; Jiang, Ru; Xu, Qin; Liang, Jianming*; Wang, Shengzheng*Journal of Medicinal Chemistry, 2023.被引 2
  • Artesunate Inhibits the Cell Growth in Colorectal Cancer by Promoting ROS-Dependent Cell Senescence and Autophagy
    Huang, Zhiying; Gan, Shu; Zhuang, Xuerong; Chen, Yao; Lu, Linlin; Wang, Ying; Qi, Xiaoxiao; Feng, Qian; Huang, Qiuju; Du, Biaoyan; Zhang, Rong*; Liu, Zhongqiu*Cells, 2022, 11(16): 2472.被引 13
查看全部 →

发表信息

论文状态
公开发表
期刊
Cancer Chemotherapy and Pharmacology
发表日期
2024-01-09
DOI
10.1007/s00280-023-04623-7
语言
ENGLISH
成果收录
SCIE
资助标注
NIH/NIDDK

作者

  • W

    Wang, Chong-Zhi (通讯) (第一作者)

    1 · yunnan univ tradit chinese med

  • W

    Wan, Chunping

    1 · yunnan univ tradit chinese med

查看全部 13 位作者收起作者
  • L

    Li, Cang-Hai

  • L

    Liang, Guo-Gang

  • L

    Luo, Yun

  • Z

    Zhang, Chun-Feng

    china pharmaceut univ

  • Z

    Zhang, Qi-Hui

    chongqing univ

  • M

    Ma, Qinge

  • W

    Wang, Angela H.

  • L

    Lager, Mallory

  • J

    Jiang, Ting-Liang

  • H

    Hou, Lifei

  • Y

    Yuan, Chun-Su

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417